The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued:

• Aminophylline Injection, USP (New – Currently in Shortage)
• Atorvastatin Calcium Tablets (New – Discontinuation)
• Atropine Sulfate Injection (Updated – Currently in Shortage)
• Bumetanide Injection, USP (Updated – Currently in Shortage)
• Cefepime Injection (Updated – Currently in Shortage)
• Cefotetan Disodium Injection (Updated – Currently in Shortage)
• Diltiazem Hydrochloride (Updated – Currently in Shortage)
• Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
• Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
• Isocarboxazid Tablets (Updated – Currently in Shortage)
• Ketamine Injection (Updated – Currently in Shortage)
• Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
• Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
• Magnesium Sulfate Injection (Updated – Currently in Shortage)
• Metformin Hydrochloride Tablets (New – Discontinuation)   
• Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
• Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
• Pantoprazole (Protonix) Powder for Injection (Currently in Shortage)
• Phenytoin Sodium Injection, USP (Updated – Currently in Shortage)
• Potassium Chloride Injection (New – Currently in Shortage)
• Progesterone Injection, USP (Updated – Currently in Shortage)
• Promethazine (Phenergan) Injection (Updated – Currently in Shortage)
• Sacrosidase (Sucraid) Oral Solution (Updated – Currently in Shortage)
• Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
• Sodium Chloride Injection USP, 0.9% Vials and Syringes (New – Currently in Shortage)
• Sterile Water (Updated – Currently in Shortage)

According to the FDA:

“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.” 

(Source: U.S. Food & Drug Adminstration)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!